acting jointly, shall assess the depth and quality of information on kidney disease that is collected in surveys and population studies conducted by the Centers for Disease Control and Prevention, including whether there are additional opportunities for information to be collected in the National Health and Nutrition Examination Survey, the National Health Interview Survey, and the Behavioral Risk Factors Surveillance System surveys. The Director of the National Institute of Diabetes and Digestive and Kidney Disease shall include the results of such assessment in the national action plan under subsection (b). (e) Authorization of appropriations There are authorized to be appropriated to carry out this section $1,000,000 for fiscal year 2021, $1,000,000 for fiscal year 2022, $1,000,000 for fiscal year 2023, $1,000,000 for fiscal year 2024, and $1,000,000 for fiscal year 2025. 799A. Home dialysis and increasing end-stage renal disease treatment modalities in minority communities action plan (a) National action plan (1) Development Not later than 2 years after the date of the enactment of this Act, the Director of the National Institute of Diabetes and Digestive and Kidney Disease, in consultation with the Director of the Centers for Disease Control and Prevention, shall develop a national action plan to increase the number of home dialyzers and choice in dialysis treatment modality in the United States with participation from patients, caregivers, health professionals, patient advocacy organizations, researchers, providers, public health professionals, and other stakeholders in the minority community. (2) Contents At a minimum, such plan shall include recommendations for— (A) public health officials for the purpose of implementation of the national plan